#CIPLA #BALPHARMA #GLENMARK #SANOFI #PFIZER #AUROPHARMA #NIFTY50#CIPLA
NSE: CIPLA
CMP: 1128
TP: 1250
SL: 1080
TF: <6m
RR > 2.5 times
Return > 11%
THYROCARE CNXPHARMA LUPIN NSE: CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER
Factors:
BULLISH WEDGE BREAKOUT
Trend Following
Rising Volume with rising Prices.
Flag pattern breakout.
Pennant Pattern Breakout with Bullish Candle.
Retest Successful.
Higher Highs & Higher Lows.
Broken above RESISTANCE levels
Trading at SUPPORT levels
Earnings are strong.
Bullish Wedge Breakout
Risk Return Ratio is healthy.
And
Rising from Double Bottom Pattern to Flag Pattern forming.
If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations.
With 💚 from Rachit Sethia
CIPLA trade ideas
Cipla 1HRCipla is looking good setup for tomorrow trade Cipla formed head and shoulder pattern
in 1 day timeframe price in a crucial level if a candle break and close below the support
we can sell cipla first target will be 1078.50 and second will be 1066.20and trail your
stoploss if cipla braking upper green zone then we can avoid this trade
Thank you
NSE:CIPLA
Cipla on 1D TF INV H&Shere the the price made a nice inverted head and shoulder formation and it can go below it if the neck line breaks and i am looking shorting oppurtunities.
this is my analysis please do your analysis and dont take any entry based on this and i am not responsible for any loss or profit that you make.
(IF YOU HAVE DOUBTS YOU CAN COMMENT)
CIPLA40 years ago, Cipla started its fight against heart disease with innovative and high-class drugs. Over the years, cipla have been developing several products that help treat various diseases like MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, and obesity.
Its API pipeline consists of 75+ complex developments in the therapy areas of Oncology, Hep C, ARV, Diabetology, CVS, CNS, Respiratory etc.
Good for long term buy on dips , for shorterm keep SL at 1090 and wait for 1287
Cipla Buying Opportunity1) The US recession talks are rising day by day. The recession is to come, we just don't know when, but it will come.
2) Inflation is at an all-time high. The IT sector is tanking like anything.
3) The Pharma sector is known to be recession-proof and inflation-proof. People will never stop spending on medicine and healthcare, no matter how expensive it gets.
4) Cipla is consolidating at its previous swing high.
5) The pharma sector has already corrected 1/3 after the 2020 rally.
6) almost all the sectors have recovered except for IT and PHarma. I believe if pharma rallies, then CIPLA will be the one leading the rally.